A BILL 
To amend the Controlled Substances Act to require warning 
labels for prescription opioids, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Lessening Addiction 
4
By Enhancing Labeling Opioids Act of 2019’’ or the 
5
‘‘LABEL Opioids Act’’. 
6
SEC. 2. AMENDMENT. 
7
(a) IN GENERAL.—Section 305(c) of the Controlled 
8
Substances Act (21 U.S.C. 825(c)) is amended— 
9
20:38 May 30, 2019
H2732
jbell on DSK3GLQ082PROD with BILLS
2 
•HR 2732 IH
(1) by inserting ‘‘(1)’’ before ‘‘The Secretary’’; 
1
and 
2
(2) by adding at the end the following: 
3
‘‘(2) The label of any container or package containing 
4
an opioid or opiate listed in schedule II, III, IV, or V shall, 
5
when dispensed (other than administered) to or for a pa-
6
tient, contain a clear, concise warning, in a manner speci-
7
fied by the Secretary by regulation, that the opioids or 
8
opiates dispensed can cause dependence, addiction, and 
9
overdose.’’. 
10
(b) REGULATIONS.— 
11
(1) REGULATIONS.—The Secretary of Health 
12
and Human Services shall prescribe regulations 
13
under section 503(b) of the Federal Food, Drug, 
14
and Cosmetic Act (21 U.S.C. 353(b)) to implement 
15
the amendment made by subsection (a) and such 
16
regulations shall be effective not later than 2 years 
17
after the date of enactment of this Act. 
18
(2) INTERIM RULES.—The Secretary of Health 
19
and Human Services may issue the regulations re-
20
quired under paragraph (1) by interim rule to the 
21
extent necessary to comply with the timing require-
22
ment in paragraph (1). 
23
Æ 
20:58 May 25, 2019
H2732
jbell on DSK3GLQ082PROD with BILLS
